Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
112.59
+5.02 (4.67%)
Jul 30, 2026, 4:00 PM EDT - Market closed
Mirum Pharmaceuticals Market Cap
Mirum Pharmaceuticals has a market cap or net worth of $6.87 billion as of July 30, 2026. Its market cap has increased by 170.88% in one year.
Market Cap
6.87B
Enterprise Value
6.80B
1-Year Change
170.88%
Ranking
Category
Stock Price
$112.59
ChartMarket Cap Chart
Since July 18, 2019, Mirum Pharmaceuticals's market cap has increased from $297.23M to $6.87B, an increase of 2,209.98%. That is a compound annual growth rate of 56.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 6.87B | 68.18% |
| Dec 31, 2025 | 4.08B | 105.67% |
| Dec 31, 2024 | 1.98B | 44.25% |
| Dec 29, 2023 | 1.38B | 91.51% |
| Dec 30, 2022 | 718.54M | 47.79% |
| Dec 31, 2021 | 486.19M | -4.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rhythm Pharmaceuticals | 7.30B |
| ImmunityBio | 7.15B |
| Cogent Biosciences | 6.76B |
| PTC Therapeutics | 6.18B |
| Erasca | 6.15B |
| Xenon Pharmaceuticals | 6.10B |
| CG Oncology | 6.10B |
| Belite Bio | 6.00B |